antipyrine has been researched along with Hepatitis C, Chronic in 5 studies
Antipyrine: An analgesic and antipyretic that has been given by mouth and as ear drops. Antipyrine is often used in testing the effects of other drugs or diseases on drug-metabolizing enzymes in the liver. (From Martindale, The Extra Pharmacopoeia, 30th ed, p29)
antipyrine : A pyrazolone derivative that is 1,2-dihydropyrazol-3-one substituted with methyl groups at N-1 and C-5 and with a phenyl group at N-2.
Hepatitis C, Chronic: INFLAMMATION of the LIVER in humans that is caused by HEPATITIS C VIRUS lasting six months or more. Chronic hepatitis C can lead to LIVER CIRRHOSIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We tested whether fibrotic progression in chronic hepatitis C could be predicted by liver tests, antipyrine clearance, or platelet count." | 7.72 | Changes in antipyrine clearance and platelet count, but not conventional liver tests, correlate with fibrotic change in chronic hepatitis C: value for predicting fibrotic progression. ( Byth, K; Coverdale, SA; Crewe, E; Farrell, GC; George, J; Kench, J; Khan, MH; Liddle, C; Lin, R; Samarasinghe, DA, 2003) |
| "We tested whether fibrotic progression in chronic hepatitis C could be predicted by liver tests, antipyrine clearance, or platelet count." | 3.72 | Changes in antipyrine clearance and platelet count, but not conventional liver tests, correlate with fibrotic change in chronic hepatitis C: value for predicting fibrotic progression. ( Byth, K; Coverdale, SA; Crewe, E; Farrell, GC; George, J; Kench, J; Khan, MH; Liddle, C; Lin, R; Samarasinghe, DA, 2003) |
| " The object of the present study was to investigate whether liver metabolic function assessed by antipyrine clearance is related to other disease characteristics influencing response to therapy in chronic hepatitis C." | 3.71 | Impairment of metabolic function in chronic hepatitis C is related to factors associated with resistance to therapy. ( Almar, M; Díaz-Golpe, V; García-Fernández, A; González-Gallego, J; Jorquera, F; Olcóz, JL, 2001) |
| " The pharmacokinetic variables for antipyrine were determined using the two concentration time points selected." | 2.73 | Antipyrine clearance in comparison to conventional liver function tests in hepatitis C virus patients. ( Abdel-Kader, R; Botros, S; Hassanein, M; Mahmoud, M; Saleh, S, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gichev, IuP | 1 |
| Gichev, IuIu | 1 |
| Grek, OR | 1 |
| Tolokonskaia, NP | 1 |
| Chernousova, NIa | 1 |
| Tomilenko, TG | 1 |
| Makkosland, K | 1 |
| Coverdale, SA | 1 |
| Samarasinghe, DA | 1 |
| Lin, R | 1 |
| Kench, J | 1 |
| Byth, K | 1 |
| Khan, MH | 1 |
| Crewe, E | 1 |
| Liddle, C | 1 |
| George, J | 1 |
| Farrell, GC | 1 |
| Schneider, AR | 1 |
| Teuber, G | 1 |
| Paul, K | 1 |
| Nikodem, A | 1 |
| Duesterhoeft, M | 1 |
| Caspary, WF | 1 |
| Stein, J | 1 |
| Mahmoud, M | 1 |
| Abdel-Kader, R | 1 |
| Hassanein, M | 1 |
| Saleh, S | 1 |
| Botros, S | 1 |
| Jorquera, F | 1 |
| Almar, M | 1 |
| Díaz-Golpe, V | 1 |
| Olcóz, JL | 1 |
| García-Fernández, A | 1 |
| González-Gallego, J | 1 |
3 trials available for antipyrine and Hepatitis C, Chronic
| Article | Year |
|---|---|
[Experience of biologically active supplements to food containing indoles and isothiocyanates in patients with chronic viral hepatitis].
Topics: Adolescent; Adult; Alanine Transaminase; Antipyrine; Aspartate Aminotransferases; Bilirubin; Case-Co | 2002 |
Patient age is a strong independent predictor of 13C-aminopyrine breath test results: a comparative study with histology, duplex-Doppler and a laboratory index in patients with chronic hepatitis C virus infection.
Topics: Adult; Aged; Aging; Antipyrine; Aspartate Aminotransferases; Breath Tests; Female; Hepatitis C, Chro | 2006 |
Antipyrine clearance in comparison to conventional liver function tests in hepatitis C virus patients.
Topics: Alanine Transaminase; Antipyrine; Aspartate Aminotransferases; Chromatography, High Pressure Liquid; | 2007 |
2 other studies available for antipyrine and Hepatitis C, Chronic
| Article | Year |
|---|---|
Changes in antipyrine clearance and platelet count, but not conventional liver tests, correlate with fibrotic change in chronic hepatitis C: value for predicting fibrotic progression.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antipyrine; Antiviral Agents; Biopsy; Disease | 2003 |
Impairment of metabolic function in chronic hepatitis C is related to factors associated with resistance to therapy.
Topics: Adult; Alanine Transaminase; Antipyrine; Antiviral Agents; Chi-Square Distribution; Drug Resistance, | 2001 |